Evaluation of post-vaccination flock immunity against Peste des Petits Ruminants (PPR) in small ruminants across selected districts of Borana zone, Southern Ethiopia Authors: Garoma Desa, Demeke Sibhatu, Fasil Aklilu, Hagos Asgedom, Ashebir Abebe, Takele Worku, Meron Moges, Melkamu Tadesse, Garru Lolo Published: 2026 ABSTRACT AbstractBackgroundPeste des Petits Ruminants (PPR) is a highly contagious transboundary viral disease affecting small ruminants, with significant socio-economic consequences in areas such as Borana Zone, Southern Ethiopia. This sero-monitoring study was conducted in Yabello, Taltale, and Elwaya districts of Borana zone to evaluate the Post-vaccination immunity status of local sheep and goats against PPR.MethodsThree stage sampling methods were used to select peasant associations (PA), villages and individual animals. A total of 901 sera samples were collected from 578 to 323 vaccinated goats and sheep, respectively. Competitive ELISA was employed as a tool of diagnosis.ResultsAn overall sero-conversion rate of 93.23% (95% CI: 91.40%-94.69%) was recorded. Statistically significant differences in sero-conversion were observed across age groups (higher in small ruminants > 2 years; P = 0.001; odds ratio = 3.35) and history of movement (higher in those having no history of migration; P = 0.04; odds ratio = 2.15). However, no significant differences were observed among species (P = 0.95; odds ratio = 1.02), sex groups (P = 0.16; odds ratio = 2), districts (P = 0.23; odds ratio = 1.66), and timing between vaccination and sampling for sero-monitoring (P = 0.06; odds ratio = 2.18).ConclusionsThe findings suggest the effectiveness of the vaccination program. The development of protective immunity in substantial proportion of goats and sheep after vaccination confirmed successful induction of flock immunity. Developing a strategy to track and manage the movement of small ruminants to minimize the introduction of unvaccinated animal is suggested.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12917-026-05665-8.Keywords: Borana, Peste des Petits Ruminants (PPR), Sero-conversion, Sero-monitoring, Small ruminants Introduction Ethiopia, a sub-Saharan African nation, possesses the largest population of small ruminants on the continent, with an estimated 42.9 million sheep and 52.5 million goats. These figures represent approximately 4% of the global and 10% of Africa’s small ruminant populations [1]. Despite this vast resource, the country has not fully capitalized on the potential benefits of the sector due to the impact of various diseases and related challenges [2, 3]. Among these, Peste des Petits Ruminants (PPR) stands out as a major infectious disease that significantly hinders the productivity of sheep and goats in Ethiopia [4, 5]. Peste des Petits Ruminants is an acute highly contagious, and economically devastating trans-boundary viral disease caused by the PPR virus (PPRV), a single-stranded RNA virus belonging to the order Mononegavirales, genus Morbillivirus, and family Paramyxoviridae [6], affecting small ruminants and posing serious socio-economic implications [7, 8]. Peste des Petits Ruminants is clinically manifested by severe pyrexia, high fever, ocular and nasal discharge, necrotizing and erosive stomatitis, pneumonia, ulceration of the mucous membrane and inflammation of gastro-intestinal tract leading to severe diarrhea [9, 10]. The primary mode of PPR transmission is through direct contact with infected animals, particularly via exposure to contaminated mucosal discharges or faecal matter [11]. Additionally, the disease spreads through aerosols during close interactions, especially when infected animals sneeze or cough [12]. Recent studies have reported PPR sero-prevalences of 47.50%, 48.43% and 37.60% in Tigray, Oromia and Somali regions of Ethiopia, respectively [13]. The disease is known for its high morbidity (80%-90%) and mortality rates (50%-80%) in endemic areas [14, 15], and [16], substantial economic losses, reduced production and productivity as well as elevated control costs [17, 18]. It remains a major cause of mortality among sheep and goats, threatening the livelihoods of subsistence farmers across various agro-ecological zones in Ethiopia [17, 19]. Vaccination is the most feasible and effective approach to control PPR [20–23]. A vaccine’s ability to prevent disease is dependent on its potency and proper administration to the animal that are capable of responding to it [24, 25]. Diagnostic tests for PPR with high sensitivity and specificity are available [26]. According to PPR global strategy, sero-monitoring is one of the tools of post-vaccination evaluation that necessitates the monitoring of population immunity periodically, depending on the country’s epidemiological situation, financial resources, and needs [27]. For this particular study, the small ruminants found in three districts of Borana zone were vaccinated with PPR vaccine to protect them from the disease. Vaccination campaigns are implemented to maintain herd immunity above 80% [28]. The country’s national PPR control program is designed to achieve the complete eradication of PPR by 2027. Ethiopia has been actively implementing a risk based vaccination campaign for small ruminants nationwide. The three selected districts in Borana Zone have been prioritized for the intensive implementation of the PPR control program due to the critical role that small-ruminant production plays in the livelihoods of pastoral communities. Furthermore, the zone was prioritized for both the previous PPR vaccination campaign and the current sero-monitoring program due to its proximity to neighboring countries, a factor that increases the risk of trans-boundary disease transmission. These activities are contributing to supporting both the national efforts and the global initiative aimed at eradicating PPR by 2030. Therefore, the current study was aimed to measure the level of flock immunity developed after vaccination against PPR vaccine. Materials and methods Description of the study areas The current sero-monitoring study was conducted from July to December, 2025 in Yabello, Taltale, and Elwaya districts of Borana zone, southern Ethiopia (Fig. 1) to measure the level of flock immunity developed Post-vaccination against PPR in small ruminants. Yabello, Elwaya and Taltale districts are located at a distance of 565, 595, and 680 Kms, respectively from Addis Ababa, capital of Ethiopia. The three districts are populated with 769,253 goats and 418,465 sheep with the highest population in Taltale district [29]. Map of the study areas, generated using Arc GIS version Arc map 10.8 esri Study animals and design Sera samples were collected from vaccinated, local Borana sheep and goat breeds, managed under extensive production system. As repeated sampling was conducted, a longitudinal study design was used during the current sero-monitoring program. Alongside serum sample collection, epidemiological data were gathered using a semi-structured questionnaire. The questionnaire was originally prepared for this purpose in English and then translated into Afaan Oromoo, the local language spoken by the community, local veterinarians who are fluent in both English and Afaan Oromoo (refer supplementary file). Sampling methods Convenient sampling method was employed to select districts and kebeles, by considering factors such as previous vaccination history of the small ruminants as well as road accessibility. The study animals were identified by species, and sampled based on their proportion. A sampling frame was not available, making it difficult to apply a simple random sampling method. However, estimates of the target population were available. Therefore, a systematic random sampling approach was employed to select both animal owners and individual animals for inclusion in the study. Regarding sample size determination, 10% of animals from vaccinated herds were sampled. Five kebeles were randomly selected from the district, followed by the random selection of three villages from each kebele and four herds from each village. An average of five animals was sampled per herd, resulting in approximately 60 animals per kebele (3 villages × 4 herds × 5 animals). Consequently, a total of 300 serum samples were collected from each seromonitoring district (60 animals × 5 kebeles). Baseline PPR data, vaccination and vaccine handling The seroprevalence of PPR in Borana was investigated and 32.10% of PPRV antibody was recorded before the implementation of vaccination campaign against PPR [30]. Animal ID was manually generated before the seroprevalence study after detail discussion with animal owners and veterinarians of the area. After laboratory test is conducted and result was known, the unique ID’s of the sero-positive shoats were given to the veterinary experts of the area. Accordingly, the sero-positive shoats were excluded during vaccination and only the sero-negative small ruminants were vaccinated subcutaneously with 1mL of live attenuated PPR vaccine (Nigerian strain 75/1) which was produced at National Veterinary Institute (NVI), Ethiopia. As the vaccine was thermolabile, a cold chain was used to ensure the correct temperature was maintained during transportation and in the field. Due to the migration of animals from place to place in search of feed, vaccination was carried out at different time intervals based on their availability. The sampling interval was irregular which has been addressed in the discussion section as a limitation. Post vaccination sampling has been conducted for the three districts at the same time while vaccination of the small ruminants has been conducted at different time due to various factors including security issue and movement for grazing. Data and blood sample collection Questionnaire survey A semi-structured questionnaire was designed to collect epidemiological data from the owners of the sampled animals. The questionnaire was presented to the owners by considering the general signs of the disease. The PPR focal person from Yabello Regional Veterinary Laboratory and animal health experts of the selected districts were asked about the time when and where vaccine was given. The following data were collected to be considered as input variables for laboratory and epidemiological analysis: these are history of migration, district, duration after migration and kebele. The age of the animals was determined based on the owners information and grouped into two age as young (< 2 years) and adult (≥ 2 years) [31]. Shoats with the age < five months and those ready for markets are not considered during vaccination while others were included in the vaccination. Kids and lambs < five months were not vaccinated and sampled during sero-monitoring due to passive maternal immunity. Blood sample collection and detection of PPR specific antibodies The small ruminants were restrained by owners, and approximately 5–7 mL of blood sample was collected from the jugular vein of each animal using plain vacutainer tube (manufactured by Becton Dickinson Company). Each sample from each animal was labeled by using codes describing the specific animal. The animal level characteristics including species, age and sex were recorded during sample collection. The blood sample was kept overnight at room temperature to allow clotting. The next morning, clearly separated serum of approximately 2 ml was decanted to the Eppendorf cryovials for laboratory analysis. The detection of PPR specific antibodies in serum of each animal was conducted at Immunology laboratory of Animal Health Institute (AHI). The AHI of Ethiopia (formerly NAHDIC) is accredited for ISO/IEC 17,025 standards by the Ethiopian accreditation service (EAS). Additionally, the institute has received international accreditation and recognition from the South African National Accreditation System (SANAS) and collaborates with the International Laboratory Accreditation Cooperation (ILAC). Sera samples were analyzed for the presence of specific PPR antibodies by IDEXX Cirad competitive ELISA PPR antibody test kit, manufactured and marketed by ID. vet (Innovative Diagnostics), based in Montpellier, France. After thorough laboratory procedure, the result was interpreted as follows. The competition percentage Where OD: Optical Density, NC: Negative Control. ▪ S/N % with the value < 50%, “Positive” ▪ S/N % with the value < 50%, “Positive” ▪ S/N% with the value >60% , “Negative “ ▪ S/N% with the value >60% , “Negative “ ▪ S/N% between 50 and ≤60 % "Doubtful” ▪ S/N% between 50 and ≤60 % "Doubtful” Data management and analysis All data obtained from the field and laboratory test result were recorded in the record sheet format, entered into the computer and managed using Microsoft Excel work sheet. Descriptive statistics was employed to summarize the data after being edited and coded; Stata software version 12 was used for statistical analysis. The sero-conversion rate was calculated for all variables by dividing the number of sero-positive animals by the total number of examined animals and multiplied by hundred. Associations between the outcome and explanatory variables for all units of analysis were examined using a binary logistic regression model. The strength of association between the outcome and explanatory variables was evaluated using odds ratios (OR). Univariate logistic regression analysis was employed to identify individual explanatory variables that could predict the outcome variable. All risk factors with a p-value of ≤ 0.25 in the univariate logistic regression analysis were included in the multivariable logistic regression analysis to control the effect confounding. P-value of less than 0.05 was set for testing significance of statistical associations between the dependent and independent variables. Results Questionnaire survey The vaccination was conducted in Elwaya, Taltale and Yabello districts, one month, two months and five months before the execution of seromonitoring program respectively. Accordingly, 285,650 small ruminants of Taltale district were vaccinated while; 181,513 and 170,000 small ruminants of Yabello and Elwaya districts respectively were also vaccinated against PPR disease. According to 80% of animal owner’s response, there was a movement of small ruminant from their kebele’s to other areas and vice versa. Post-vaccination seroconversion To assess the sero-conversion rate following the administration of Peste des Petits Ruminants (PPR) vaccine, a total of 901 sera samples were collected; 578 from goats and 323 from sheep. In general, the analysis of the collected sera revealed that a significant portion of the vaccinated population had developed protective immunity. Specifically, 93.23% (95% CI: 91.40% − 94.69%) of the sampled animals tested sero-positive for PPR antibodies, indicating very good immunological response to the vaccine. However, the results also showed that 5.11% of the animals did not develop sufficient immunity and 1.66% of the samples yielded doubtful results (Table 1). Table 1Sero-conversion rate across different variablesVariableCategoryTested animalsSero-positive animalsSero-conversion rate (%)DistrictYabello30127491.03Elwaya30028896Taltale30027892.67SpeciesCaprine57854594.29Ovine32329591.33SexFemale74570494.50Male15613687.18Age< 237032988.92 > 2 53151196.23Duration after vaccinationOne month30028896Two months30027892.67Five months30127491.03History of migrationPresent42138491.21Absent48045695 Sero-conversion rate across different variables According to the univariate analysis, the p-value of all variables were greater than 0.25 and subjected to multivariate analysis to identify the potential influencing factors. Specially, the small ruminants with the age group of ≥ 2 years (p = 0.001; χ² = 18.91; OR = 3.35 with 95% CI of 1.76–6.39) and having no history of migration (p = 0.04; χ² = 9.01; OR = 2.15 with 95% CI: 0.96–3.51) have shown significantly higher seroconversion rate in the univariate logistic regression analysis (Table 2). Table 2Univariate analysis results for the variablesVariableCategorySero-conversion rate (%)P-valueχ²DistrictYabello91.030.237.12Elwaya96Taltale92.67SpeciesCaprine94.290.959.38Ovine91.33SexFemale94.500.164.02Male87.18Age< 2 years88.920.00118.91≥ 2 years96.23Duration after vaccinationOne month960.067.12Two months92.67Five months91.03History of migrationAbsent950.049.01Present91.21Ref Reference Univariate analysis results for the variables Ref Reference Potential influencing factors Based on multivariate logistic regression analysis output, only age (p = 0.001, OR = 3.29; 95% CI = 1.7–6.36) and history of migration (p = 0.04, OR = 1.94; 95% CI = 1.02–3.67) have shown statistical significant difference and considered as a potential influencing factors (Table 3). Table 3Potential influencing factorsVariableCategorySero-conversion rate (%)P-valueOR (95% CI)Age< 2 years88.920.0013.29 (1.7–6.36)≥ 2 years96.23History of migrationAbsent950.041.94 (1.02–3.67)Present91.21 Potential influencing factors Discussion The present sero-monitoring study for PPR antibodies was conducted under field (natural) conditions, utilizing 901 sera samples collected from small ruminants that had previously received a vaccine against PPR. Laboratory analysis revealed that 840 out of 901 animals tested had developed protective levels of antibodies, corresponding to sero-conversion rate of 93.23% (95% CI: 91.40% − 94.69%), indicating a strong and statistically reliable immune response among the vaccinated population. This remarkable flock immunity was achieved through good vaccine management practices, including strict adherence to cold chain protocols and effective vaccination delivery [32]. Despite this high level of protection, 46 animals (5.11%) failed to mount a sufficient immune response and were therefore considered seronegative. This might be attributable to the turnover of the vaccinated and introduction of unvaccinated animals to the herd. Importantly, the overall sero-conversion rate observed in this study surpassed the minimum threshold recommended by the Global Strategy for the Control and Eradication (GSCE) of PPR, which advocates that at least 80% of vaccinated animals should seroconvert to establish an effective herd immunity barrier [28]. The findings from this seromonitoring effort suggest that the current vaccination campaign in Yabello, Elwaya and Taltale is not only effective but is exceeding international targets, contributing significantly toward the national and global goals of PPR eradication [20]. This result was in agreement with the findings of Yirga et al. [33]., Banik et al. [34] and Ahamed et al. [35] who reported Post-vaccination immunity of 93.90%, 94.92% and 96%, respectively. In contrast, the current sero-conversion result is by far higher than the findings of Yirga et al. [33]., Faris et al. [36]., Balamurugan et al. [37]. and Luka et al. [38]., who reported 68% in vaccinated small ruminants of Amhara region, Ethiopia, 61.13% in vaccinated small ruminants of Awash Fentale district of Afar region, Ethiopia, 73.4% in vaccinated small ruminants in India and 55.26% among PPR vaccinated small ruminants in Uganda respectively. The suboptimal herd immunity observed in previous studies may be attributed to improper vaccine handling and administration, animal population turnover with the introduction of unvaccinated animals, variations in agro-climatic conditions across different regions, and differences in diagnostic test methods, particularly to their sensitivity and specificity [39–42]. Post-vaccination sero-conversion rates varied across different factors. A statistically significant difference was observed among different age groups (P < 0.05), with small ruminants older than two years showing a higher rate of immunity development following vaccination. This outcome could be attributed to the uncontrolled movement and transfer of animals as gifts and supply to markets. In contrast, younger animals under the age of two years may have been replaced or supplemented by recently born, unvaccinated young animals. These unvaccinated animals might have been inadvertently included in the sero-monitoring study, which could have led to an underestimation of sero-conversion rates with in this age category due to unregulated movement. In addition, according to Altman et al. [24] and Giefing-Kroll et al. [43], vaccine effectiveness is affected by the age. A statistically significant difference was also noted in the development of Post-vaccination flock immunity between small ruminants with a history of migration and those that remained stationary. Specifically, animals that had no history of migration exhibited a higher rate of flock immunity following vaccination. In contrast, the lower sero-conversion rate observed in migratory small ruminants could potentially be explained by the unintentional inclusion of unvaccinated animals during the sero-monitoring activities, which may have led to an underestimation of the true Post-vaccination immunity level in this group. That means, herd immunity could be influenced due to the rapid turnover including sales, cultural practices, gifts, etc. observed in small ruminants [29]. The introduction of new animals into a herd through acquisition or gift is a common practice in Ethiopia. Thus, unvaccinated animals entering the vaccinated herd could lower the herd immunity. Similarly, the removal of immunized animals for the same reasons could dilute already-formed herd immunity [44]. These all factors can affect the anticipated sero-conversion rate and protective barrier at the herd level. Although the differences in sero-conversion rates among the various districts were not statistically significant, a relatively higher sero-conversion rate was recorded in Elwaya district (96%), followed by Taltale (92.67%) and Yabello (91.03%). The notably higher sero-conversion rate observed in Elwaya could possibly be due to the shorter time interval between vaccination and sampling. Elwaya district received the PPR vaccine one month prior to the sero-monitoring activity, whereas Taltale and Yabello received the vaccine two months and five months earlier, respectively. This shorter interval between vaccination and sero-monitoring in Elwaya likely contributed to the higher detectable antibody levels. No statistical significant difference was observed (P > 0.05) in post-vaccination flock immunity when comparing different species and sex groups of small ruminants, nor was there a significant association between the time interval from vaccination to the date of sero-monitoring and the level of sero-conversion. The limitation of this study is lack of a standardized time interval between vaccination and sero-monitoring across the three districts. To accurately assess and compare the immune response to vaccination, the sero-monitoring should have been conducted at the same Post-vaccination interval in all locations. However, the timing varied, being one month in one district, two months in another, and five months in the third, which may have influenced the comparability of sero-conversion rates among districts. In addition, the number of animals selected for sampling in this study was very small relative to the number of vaccinated animals reported, which may reduce precision and increase sampling error. Conclusion and recommendations This study demonstrated a high level of Post-vaccination sero-conversion in small ruminants across three districts of Borana Zone. The herd immunity documented in this study is exceeding the minimum threshold recommended by the Global Strategy for the Control and Eradication (GSCE) of PPR. Significant factors influencing the level of Post-vaccination immunity included age and migration history. Despite the overall success, the presence of sero-negative results highlights the need for continued sero-monitoring of small ruminant populations to ascertain if they are within acceptable herd immunity thresholds. Based on the above concluding remarks, the following recommendations are forwarded: Develop strategies to track and manage the movement of small ruminants from unvaccinated areas into vaccinated areas and vice versa, particularly in pastoral communities. Develop strategies to track and manage the movement of small ruminants from unvaccinated areas into vaccinated areas and vice versa, particularly in pastoral communities. Continue strict adherence to cold chain protocols and ensure timely vaccine delivery to maximize immunogenicity. Continue strict adherence to cold chain protocols and ensure timely vaccine delivery to maximize immunogenicity. Conduct longitudinal studies to evaluate the duration of Post-vaccination immunity and investigate sero-conversion dynamics across different agro-ecological zones. Conduct longitudinal studies to evaluate the duration of Post-vaccination immunity and investigate sero-conversion dynamics across different agro-ecological zones. Supplementary Information Supplementary Material 1. Acknowledgements We thank Livestock and Fisheries Sector Development Project (LFSDP) for their financial support during sample collection and Animal Health Institute (AHI) for providing us with laboratory consumables. Authors’ contributions GD: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, writing original draft. DS, FA and HA: Conceptualization, Funding acquisition, Supervision, Investigation, Review, editing and Validation. AA: Data curation, Formal analysis, Investigation, Methodology. TW, MM and MT: Conceptualization, Funding acquisition, Supervision, Review, editing and validation. GL: Conceptualization, Data curation, Formal analysis, Investigation, Methodology. Funding The research work was funded by Livestock and Fisheries Sector Development Project (LFSDP), and Animal Health Institute (AHI). Data availability The data used to support the findings of this study can be received from the corresponding author on request. Declarations Ethics approval and consent to participate The purpose of the research was clearly explained to the animal owners and veterinary personnel of the area, and informed consents were obtained from the owners. The current study did not involve any experimental procedures on live animals and only utilized blood samples collected by qualified animal practitioners without any additional harm or distress to the animals. It was conducted to support the ongoing PPR eradication program and not for research. Therefore, according to the guidelines of the Animal Health Institute (AHI), the study was believed exempt from the necessity for formal animal ethical clearance. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The data used to support the findings of this study can be received from the corresponding author on request.